Genre
- Journal Article
We have tested the hypothesis that H-ras transformed cells contain alterations in signal pathways important in controlling the expression of ornithine decarboxylase (ODC), the highly regulated rate-limiting activity in the biosynthesis of polyamines. Mouse 10T1/2 fibroblasts and a series of 10T1/2 H-ras transformed cell lines were treated with stimulators of cAMP synthesis (forskolin and cholera toxin), a biologically stable analogue of cAMP (8-bromo-cAMP), and an inhibitor of cAMP degradation (3-isobutyl-1-methylxanthine). Elevations in ODC gene expression were noted in H-ras transformed cells that were not observed in parental 10T1/2 fibroblasts. The forskolin-mediated effects were not detected with 1,9-dideoxyforskolin, a compound structurally related to forskolin, which does not activate adenyl cyclase. The effects observed with cholera toxin were not detected when cells were treated with the purified subunits of this compound, indicating that the toxin-induced effects were cAMP-specific. Actinomycin D treatment prior to forskolin exposure reduced the elevation observed in ODC gene expression indicating the involvement of the transcriptional process. Furthermore, we observed that cycloheximide treatment of malignant but not benign H-ras transformed cells significantly elevated ODC message level. Treatment of malignant cells with both cycloheximide and forskolin together resulted in a further additive elevation in ODC message, but a similar treatment of benign tumor cells reduced the forskolin-mediated increase in ODC message. In addition, treatment of H-ras transformed cells with the tumor promoter, 12-0-tetradecanoylphorbol-13-acetate (TPA) led to an elevation in ODC mRNA levels not observed in parental 10T1/2 fibroblasts. However, an increase in ODC message levels was observed in parental 10T1/2 cells treated with a combination of TPA and forskolin. Exposure of H-ras transformed cells to TPA and forskolin together led to further pronounced increases in ODC message when compared to treatment with TPA or forskolin alone. These results demonstrate aberrant regulation of signal pathways involved in controlling ODC gene expression in H-ras transformed cells and provide further insight into the altered growth regulatory program associated with malignant transformation. (C) 1994 Wiley-Liss, Inc.
UNIV MANITOBA,MANITOBA INST CELL BIOL,WINNIPEG,MB R3E 0V9,CANADA.
NEW YORK; DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
WILEY-LISS
PT: J; CR: BOYTON AL, 1983, ADV CYCLIC NUCLEOTID, P193 CHOY BK, 1989, BIOCHEM BIOPH RES CO, V162, P1417 COOK SJ, 1993, SCIENCE, V262, P1069 EDWARDS DR, 1985, MOL CELL BIOL, V5, P3280 EGAN SE, 1987, MOL CELL BIOL, V7, P830 FIDLER IJ, 1977, SCIENCE, V197, P893 FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456 GILMAN AG, 1987, ANNU REV BIOCHEM, P615 GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666 GOUGH NM, 1988, ANAL BIOCHEM, V173, P93 GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300 HAYASHI S, 1989, ORNITHINE DECARBOXYL HIBSHOOSH H, 1991, ONCOGENE, V6, P739 HOLTTA E, 1986, J BIOL CHEM, V261, P9502 HURTA RAR, 1991, J BIOL CHEM, V266, P24097 HURTA RAR, 1992, J BIOL CHEM, V267, P7066 HURTA RAR, 1993, J CELL PHYSIOL, V156, P272 HURTA RAR, 1994, J CELL PHYSL, V158, P187 KAHANA C, 1985, J BIOL CHEM, V260, P15390 KATZ A, 1987, MOL CELL BIOL, V7, P2641 KONTULA KK, 1984, P NATL ACAD SCI USA, V81, P731 LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442 LE AQ, 1992, J BIOL CHEM, V267, P1072 MCCLARTY GA, 1987, BIOCHEMISTRY-US, V26, P8004 MCCLARTY GA, 1988, BIOCHEM BIOPH RES CO, V154, P975 MCCLARTY GA, 1990, J BIOL CHEM, V265, P7539 MORRS DR, 1981, POLYAMINES BIOL MED, P3 NISHIZUKA Y, 1988, NATURE, V334, P661 OLSON EN, 1986, MOL CELL BIOL, V6, P2792 PEGG AE, 1988, CANCER RES, V48, P759 PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297 PHILLIPS DR, 1986, BIOCHEMISTRY-US, V25, P7355 QURESHI SA, 1991, MOL CELL BIOL, V11, P102 RUSSELL DH, 1968, P NATL ACAD SCI USA, V60, P1420 SCHWARZ LC, 1988, CANCER RES, V48, P6999 SCHWARZ LC, 1990, GROWTH FACTORS, V3, P115 SERTICH GJ, 1987, BIOCHEM BIOPH RES CO, V143, P424 SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305 STRYER L, 1986, ANN REV CELL BIOL, P391 TABOR CW, 1984, ANNU REV BIOCHEM, P749 WRIGHT JA, 1990, ANTICANCER RES, V10, P1247 WRIGHT JA, 1990, BIOCH CELL BIOL, V68, P1364 WRIGHT JA, 1993, CRIT REV ONCOGENESIS, V4, P473 WU J, 1993, SCIENCE, V262, P1065 YOSHIDA M, 1992, CANCER RES, V52, P6671; NR: 45; TC: 13; J9: J CELL PHYSIOL; PG: 9; GA: QF854
Source type: Electronic(1)
Language
- English
Subjects
- physiology
- inhibition
- EXPRESSION
- GROWTH-FACTOR
- FIBROBLASTS
- ELEVATED
- FACTOR-BETA-1
- Cell Biology
- MESSENGER-RNA
- HYDROXYUREA RESISTANCE
- ACTIVATED PROTEIN-KINASE
- DNA
- MAMMALIAN RIBONUCLEOTIDE REDUCTASE